A conservative coalition is pushing a plan to repeal the Affordable Care Act (ACA), but centrist Republicans getting ready for the midterm elections have no interest in it; the World Health Organization has unveiled the 11th version of its International Classification of Diseases (ICD-11); doctors in Puerto Rico are seeing a stunning rise in the number and severity of asthma cases that they attribute to destruction caused by Hurricane Maria last September.
A conservative coalition made up of representatives from the Heritage Foundation, American Enterprise Institute, Galen Institute, and Manhattan Institute is pushing a plan to repeal the Affordable Care Act (ACA), but centrist Republicans getting ready for the midterm elections have no interest in it, The Wall Street Journal reported. The plan would end national consumer protections, focus on health savings accounts and block grants, and turn healthcare back to the states. Meanwhile, a bipartisan group of governors from Ohio, Colorado, Alaska, Pennsylvania, Nevada, North Carolina, Montana, Washington, and Maryland issued a joint statement against the Trump administration’s decision to not defend the ACA in federal court, saying it could hurt their residents with pre-existing conditions, the Associated Press reported.
The World Health Organization (WHO) has unveiled the 11th version of its International Classification of Diseases (ICD-11); if adopted by members, it will take effect in 2022. Providers use the codes to track injuries, diseases, and causes of death. The codes also are used by health insurers and health researchers. Some of the proposed changes include moving gender incongruence from mental disorders to sexual health conditions, adding video gaming disorder to addictive disorders, and moving stroke from a circulatory disease to a neurological disease.
Doctors in Puerto Rico are seeing a stunning rise in the number and severity of asthma cases that they attribute to destruction caused by Hurricane Maria last September, The Washington Post reported. The chronic lung disease is caused by factors like pollution, airborne mold, and pollen, all of which have increased post Maria, as mold, cockroaches, rats, mice, and mold invade dwellings. Before the hurricane, 13.3% of the island’s 3.3 million residents had asthma, compared with 8.3% on the mainland.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More